
CRISPR-Cas systems, naturally found in oral microbes, function as adaptive immune systems aiding in biofilm formation, gene transfer, and immune response modulation. These systems are being utilized as precision tools to edit genes linked with periodontal diseases, such as periodontitis, and to deliver antimicrobial agents, addressing antimicrobial resistance. With advancements in CRISPR-based therapies, their role in understanding and treating periodontal diseases is gaining prominence. This review explores CRISPR's potential in periodontal disease pathogenesis and precision therapy.
Like
Save
Share